Stand Up To Cancer dream team tackles t-cell lymphoma, focused on CAR-based strategies

(Stand Up To Cancer) A new $8 million SU2C Dream Team is focused on therapies for T-cell lymphoma using CARs to trigger the immune system to attack and destroy cancerous cells led by Helen Heslop, M.D., Baylor College of Medicine, co-led by Gianpietro Dotti, M.D., UNC Chapel Hill: seeking to develop " off the shelf " CAR cells improving availability& lowering cost; identifying biomarkers to track therapy effectiveness; evaluating a novel small molecule which shows potential as a cytoreductive regimen.

https://www.eurekalert.org/pub_releases/2019-01/sutc-sut012819.php

Source: EurekAlert! - Cancer - January 28, 2019 Category: Cancer & Oncology Source Type: news

More News: Baylor College of Medicine | Cancer | Cancer & Oncology | Lymphoma | T-cell Lymphoma